Bio Path reported $-2.85M in Net Income for its fiscal quarter ending in March of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -5.77M 2.26M Jun/2023
Baxter International USD -1.13B 1.08B Dec/2025
Bio Path USD -2.85M 99K Mar/2025
Cipla INR 6.76B 6.75B Dec/2025
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD -6.98M 360K Sep/2025
CSL USD 401M 96.5M Dec/2025
Grifols EUR 148.4M 15.76M Sep/2025
Karyopharm Therapeutics USD -30.78M 1.29M Dec/2024